News
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
2d
MedPage Today on MSNADA Roundup: Weight-Loss Studies Take Center StageBelow are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...
1don MSN
As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...
The effect of Novo Nordisk’s amycretin injections on body weight showed no signs of plateauing after 36 weeks, suggesting the ...
A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results